DELTA Trademark

Trademark Overview

On Wednesday, July 25, 2001, a trademark application was filed for DELTA with the United States Patent and Trademark Office. The USPTO has given the DELTA trademark a serial number of 76289617. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Thursday, May 16, 2002. This trademark is owned by 50-Plus Pharmacy Inc.. The DELTA trademark is filed in the Education & Entertainment Services category with the following description:

Diabetes screenings,education in the self-management of diabetes including but not limited to pathophysiology,causes,therapy,monitoring and outcome improvement
delta

General Information

Serial Number76289617
Word MarkDELTA
Filing DateWednesday, July 25, 2001
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateThursday, May 16, 2002
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing1000 - Typeset: Word(s) / letter(s) / number(s)
Published for Opposition DateNOT AVAILABLE

Trademark Statements

Goods and ServicesDiabetes screenings,education in the self-management of diabetes including but not limited to pathophysiology,causes,therapy,monitoring and outcome improvement

Classification Information

International Class041 - Education; providing of training; entertainment; sporting and cultural activities.
US Class Codes100, 101, 107
Class Status Code6 - Active
Class Status DateTuesday, August 7, 2001
Primary Code041
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party Name50-Plus Pharmacy Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressIndependence, MO 64050

Trademark Events

Event DateEvent Description
Thursday, May 16, 2002ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Friday, February 1, 2002UNRESPONSIVE/DUPLICATE PAPER RECEIVED
Tuesday, September 25, 2001NON-FINAL ACTION MAILED
Wednesday, September 19, 2001ASSIGNED TO EXAMINER

Related Keywords

delta diabetes causes therapy monitoring improvement outcome pathophysiology limited screenings education